.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Army
McKinsey
Queensland Health
Accenture
Mallinckrodt
AstraZeneca
Chinese Patent Office
US Department of Justice
Covington

Generated: November 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLARGINE RECOMBINANT

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Us Services
TOUJEO SOLOSTAR
insulin glargine recombinant
SOLUTION;SUBCUTANEOUS206538NDASanofi-Aventis U.S. LLC0024-5869-033 SYRINGE in 1 CARTON (0024-5869-03) > 1.5 mL in 1 SYRINGE (0024-5869-01)
Sanofi Us Services
TOUJEO SOLOSTAR
insulin glargine recombinant
SOLUTION;SUBCUTANEOUS206538NDASanofi-Aventis U.S. LLC0024-5869-055 SYRINGE in 1 CARTON (0024-5869-05) > 1.5 mL in 1 SYRINGE (0024-5869-01)
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAsanofi-aventis U.S. LLC0088-2219-001 SYRINGE in 1 PACKAGE (0088-2219-00) > 3 mL in 1 SYRINGE
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAsanofi-aventis U.S. LLC0088-2219-055 SYRINGE in 1 PACKAGE (0088-2219-05) > 3 mL in 1 SYRINGE
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAsanofi-aventis U.S. LLC0088-2220-3310 mL in 1 VIAL, GLASS (0088-2220-33)
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAsanofi-aventis U.S. LLC0088-5020-011 SYRINGE in 1 PACKAGE (0088-5020-01) > 3 mL in 1 SYRINGE
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAsanofi-aventis U.S. LLC0088-5020-055 SYRINGE in 1 PACKAGE (0088-5020-05) > 3 mL in 1 SYRINGE
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAsanofi-aventis U.S. LLC0088-5021-011 VIAL, GLASS in 1 PACKAGE (0088-5021-01) > 10 mL in 1 VIAL, GLASS
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAA-S Medication Solutions50090-0876-010 mL in 1 VIAL, GLASS (50090-0876-0)
Sanofi Aventis Us
LANTUS
insulin glargine recombinant
INJECTABLE;INJECTION021081NDAA-S Medication Solutions50090-1398-05 SYRINGE in 1 PACKAGE (50090-1398-0) > 3 mL in 1 SYRINGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Fuji
Citi
Harvard Business School
Colorcon
UBS
Julphar
Farmers Insurance
Healthtrust

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot